Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.59 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.50 |
| ▸ | HTT | P42858 | 2/20 | 0.49 |
| ▸ | GAA | P10253 | 1/20 | 0.49 |
| ▸ | MEN1 | O00255 | 2/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.48 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.48 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.48 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.48 |
| ▸ | RAB9A | P51151 | 1/20 | 0.48 |
| ▸ | PLAU | P00749 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | GLA | P06280 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31255154 | 1.00 | TDP1 (0.59) | TDP1L3MBTL1KMT2AALDH1A1HTT | |
| SCHEMBL28205018 | 0.89 | TDP1 (0.61) | TDP1L3MBTL1KMT2AALDH1A1HTT | |
| SCHEMBL19584403 | 0.85 | TDP1 (0.56) | TDP1L3MBTL1KMT2AALDH1A1HTT | |
| SCHEMBL31255260 | 0.83 | TDP1 (0.58) | TDP1L3MBTL1KMT2AALDH1A1HTT | |
| SCHEMBL1722652 | 0.83 | TDP1 (0.58) | TDP1L3MBTL1KMT2AALDH1A1HTT | |
| SCHEMBL30478413 | 0.83 | TDP1 (0.58) | TDP1L3MBTL1KMT2AALDH1A1HTT | |
| SCHEMBL11982024 | 0.83 | TDP1 (0.58) | TDP1L3MBTL1KMT2AALDH1A1HTT | |
| SCHEMBL2278694 | 0.83 | TDP1 (0.58) | TDP1L3MBTL1KMT2AALDH1A1HTT | |
| SCHEMBL9290492 | 0.83 | TDP1 (0.58) | TDP1L3MBTL1KMT2AALDH1A1HTT | |
| SCHEMBL635541 | 0.83 | TDP1 (0.58) | TDP1L3MBTL1KMT2AALDH1A1HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 81 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026099838-A1 | AN IMPROVED PROCESS FOR THE PREPARATION OF FLUOPYRAM | BEST AGROLIFE LIMITED (IN) | 2026-05-15 | — | — | WO | claimed |
| CN-118772049-B | Preparation process of 3-chloro-2-aminoethyl-5-trifluoromethyl pyridine | 山东滨农科技有限公司 | 2025-04-11 | — | — | CN | claimed |
| CN-118772049-A | Preparation process of 3-chloro-2-aminoethyl-5-trifluoromethyl pyridine | 山东滨农科技有限公司 | 2024-10-15 | — | — | CN | claimed |
| WO-2026099838-A1 | AN IMPROVED PROCESS FOR THE PREPARATION OF FLUOPYRAM | BEST AGROLIFE LIMITED (IN) | 2026-05-15 | — | — | WO | disclosed |
| EP-4638436-A1 | PRMT5 INHIBITORS AND USES THEREOF | GILEAD SCIENCES, INC. (US) | 2025-10-29 | — | — | EP | disclosed |
| US-12428397-B2 | Factor XI activation inhibitors | MERCK SHARP & DOHME LLC (US) | 2025-09-30 | — | — | US | disclosed |
| CN-120441476-A | Synthesis method of 2- (3-chloro-5- (trifluoromethyl) pyridin-2-yl) acetonitrile | 天津均凯农业科技有限公司 | 2025-08-08 | — | — | CN | disclosed |
| EP-4149917-B1 | FACTOR XI ACTIVATION INHIBITORS | MERCK SHARP & DOHME LLC (US) | 2025-07-30 | — | — | EP | disclosed |
| CN-118772049-B | Preparation process of 3-chloro-2-aminoethyl-5-trifluoromethyl pyridine | 山东滨农科技有限公司 | 2025-04-11 | — | — | CN | disclosed |
| CN-118772049-B | Preparation process of 3-chloro-2-aminoethyl-5-trifluoromethyl pyridine | 山东滨农科技有限公司 | 2025-04-11 | — | — | CN | disclosed |
| CN-118772049-A | Preparation process of 3-chloro-2-aminoethyl-5-trifluoromethyl pyridine | 山东滨农科技有限公司 | 2024-10-15 | — | — | CN | disclosed |
| US-20020025976-A1 | Thiazole compounds and pharmaceutical compositions for inhibiting protein kinases and methods for their use | AGOURON PHARMACEUTICALS, INC. | 2002-02-28 | — | — | US | disclosed |
| US-20020019527-A1 | Substituted phenyl farnesyltransferase inhibitors | ABBOTT LABORATORIES | 2002-02-14 | — | — | US | disclosed |
| CN-1335847-A | Sulfonamide compound and pharmaceutical use thereof | FUJISAWA PHARMACEUTICAL CO (JP) | 2002-02-13 | — | — | CN | disclosed |
| CN-1335837-A | Imidazole compounds and medicinal use thereof | FUJISAWA PHARMACEUTICAL CO (JP) | 2002-02-13 | — | — | CN | disclosed |
| WO-2001081316-A2 | SUBSTITUTED PHENYL FARNESYLTRANSFERASE INHIBITORS | ABBOTT LABORATORIES (US) | 2001-11-01 | — | — | WO | disclosed |
| EP-1142879-A1 | IMIDAZOLE COMPOUNDS AND MEDICINAL USE THEREOF | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2001-10-10 | — | — | EP | disclosed |
| EP-1136492-A1 | SULFONAMIDE COMPOUNDS AND USES THEREOF AS MEDICINES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2001-09-26 | — | — | EP | disclosed |
| WO-2001011965-A1 | FUNGICIDES | AVENTIS CROPSCIENCE GMBH (DE) | 2001-02-22 | — | — | WO | disclosed |
| WO-2001012604-A1 | FUNGICIDES | AVENTIS CROPSCIENCE GMBH (DE) | 2001-02-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020025976-A1 | Thiazole compounds and pharmaceutical compositions for inhibiting protein kinases and methods for their use | BRAF, CDK2, CHUK | TDP1 891/4885L3MBTL1 4722/4885KMT2A 4434/4885 |
| US-12428397-B2 | Factor XI activation inhibitors | F11, TFPI, F13B | TDP1 2384/4885L3MBTL1 4627/4885KMT2A 3010/4885 |
| US-20020019527-A1 | Substituted phenyl farnesyltransferase inhibitors | FNTA, FNTB, SLC10A1 | TDP1 1874/4885L3MBTL1 2965/4885KMT2A 3687/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.